Form 4: Mangoceuticals CEO Transfers 800,000 Shares to Tiger Cub Trust in Non-Beneficial Ownership Change

Mangoceuticals CEO Jacob D. Cohen transferred 800,000 shares of common stock to The Tiger Cub Trust, a trust he controls, without altering beneficial ownership.

Summary

• On August 26, 2024, Jacob D. Cohen, CEO, Director, and 10% Owner of Mangoceuticals, Inc., transferred 800,000 shares of common stock to The Tiger Cub Trust.
• This transfer is reported as a gift and did not result in a change of beneficial ownership, as Mr. Cohen controls the trust.
• Following the transaction, Mr. Cohen directly owns 0 shares, while The Tiger Cub Trust holds 9,075,000 shares.
• Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a share transfer. It doesn't inherently convey positive or negative sentiment.

Management Comments

• Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein.

Industry Context

This is a routine disclosure related to insider transactions and doesn't necessarily indicate a strategic shift for Mangoceuticals.

Key Dates

Keywords

Mangoceuticals, Jacob D. Cohen, Tiger Cub Trust, share transfer, beneficial ownership, MGRX, Form 4